共 36 条
[2]
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma:: Results at 2 years (FNCLCC-GORTEC)
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2006, 64 (04)
:983-994
[4]
Clark JW, 2006, CANC CHEMOTHERAPY BI, P641
[5]
Clarkson JE, 2010, COCHRANE DB SYST REV, V8